盎塞 ASGN 深 沪
已收盘 04-02 16:00:00 美东时间
39.05
+0.580
+1.51%
华盛通- 最 高39.725
- 今 开37.93
- 成交量 38.62万股
- 最 低 37.44
- 昨 收 38.47
- 总市值 16.13亿
- 52周最高 60.96
- 市盈率 静 15.00
- 换手率 0.94%
- 52周最低 34.59
- 委 比 76.99%
- 总股本 4130.00万
- 历史最高 131.89
- 量 比 0.67
- 振 幅 5.94%
- 历史最低 6.27
- 每 手 1
- 风险率 5.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | 盎塞 2025财年年度营收39.80亿美元，同比下降2.9%；归母净利润1.14亿美元，同比下滑34.9%
华盛资讯2月25日讯，盎塞公布2025财年年度业绩，公司年度营收39.80亿美元，同比下降2.9%，归母净利润1.14亿美元，同比下滑34.9%。
02-25 19:40
Cloudaware And ASGN's Apex Systems Team Up To Deliver Next-Generation FinOps Solutions
Cloudaware, a premier cloud governance and optimization platform, and Apex Systems, a leading global technology solutions firm and one of six ASGN brands that will be unifying under the new Everforth brand (NYSE:ASGN),
02-19 02:11
美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
财报速睇 | 盎塞 2025财年Q4营收9.80亿美元，同比下降0.5%；归母净利润0.25亿美元，同比下滑40.5%
华盛资讯2月6日讯，盎塞公布2025财年Q4业绩，公司Q4营收9.80亿美元，同比下降0.5%，归母净利润0.25亿美元，同比下滑40.5%。
02-06 06:20
ASGN shares are trading lower after the company reported mixed Q4 financial results.
ASGN shares are trading lower after the company reported mixed Q4 financial res...
02-05 22:25
Wells Fargo Maintains Equal-Weight on ASGN, Raises Price Target to $54
Wells Fargo analyst Jason Haas maintains ASGN (NYSE:ASGN) with a Equal-Weight and raises the price target from $49 to $54.
02-05 22:14
ASGN Q4 Adj. EPS $1.15 Misses $1.18 Estimate, Sales $980.100M Beat $973.274M Estimate
ASGN (NYSE:ASGN) reported quarterly earnings of $1.15 per share which missed the analyst consensus estimate of $1.18 by 2.21 percent. This is a 10.16 percent decrease over earnings of $1.28 per share from the same period
02-05 05:08
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
Truist Securities Maintains Buy on ASGN, Raises Price Target to $60
Truist Securities analyst Tobey Sommer maintains ASGN (NYSE:ASGN) with a Buy and raises the price target from $50 to $60.
01-27 23:47
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
